Catheter Ablation of Atrial Fibrillation Persistent Atrial Fibrillation Catheter Ablation : where are we?

Similar documents
High density substrate mapping In AF

Ablation of persistent AF Is it different than paroxysmal?

Surgical Ablation for Lone AF: What have we learned after 30 years?

Is cardioversion old hat? What is new in interventional treatment of AF symptoms?

Catheter ablation in AF patients with heart failure. What is possible?

Surgical AF Ablation : Lesion Sets and Energy Sources. What are the data? Steven F Bolling, MD Cardiac Surgery University of Michigan

The EP Perspective: Should We Do Hybrid Ablation, and Who Should We Do It On?

Hybrid Surgical Ablation in South America: Lesson Learned. Joao R. Breda

Long Standing Persistent AF ; CPVI is enough for it

Role of LAA isolation in AF cure

Linear Ablation Should Not Be a Standard Part of Ablation in Persistent AF. Disclosures. LA Ablation vs. Segmental Ostial Ablation With PVI for PAF

Individualised strategy approach to AF ablation

Should hybrid ablation be the standard of care instead of transcatheter ablation techniques?

Fibrillazione atriale e scompenso: come interrompere il circolo vizioso.

Interventional solutions for atrial fibrillation in patients with heart failure

In Whom and When Should Atrial Fibrillation Ablation be Considered?

Stand alone maze: when and how?

Catheter Ablation of Atrial Fibrillation Strategy and Outcome Predictors Shih-Ann Chen MD

CARDIOLOGY GRAND ROUNDS

The HISTORIC-AF TRIAL

Outcomes of AF Ablation

Scompenso cardiaco e F A : ruolo della ablazione transcatetere. Prof. Fiorenzo Gaita

Atrial Fibrillation Ablation: in Whom and How

ΚΑΤΑΛΥΣΗ ΚΟΛΠΙΚΗΣ ΜΑΡΜΑΡΥΓΗΣ. ΥΠΕΡ. Michalis Efremidis MD Second Department of Cardiology Evangelismos General Hospital

Catheter ablation of AF Where do we stand, where do we go?

SURGICAL ABLATION OF ATRIAL FIBRILLATION DURING MITRAL VALVE SURGERY THE CARDIOTHORACIC SURGICAL TRIALS NETWORK

Catheter ablation of atrial fibrillation: Indications and tools for improvement of the success rate of the method. Konstantinos P.

Atrial Fibrillation: Catheter Ablation with New Technologies, Improving Quality of Life and Outcomes in Various Disease States

Catheter Ablation for Persistent Atrial Fibrillation

Catheter Ablation for Atrial Fibrillation: Patient Selection and Outcomes

Biatrial Maze or PVI to Ablate Afib? Marc Gillinov, MD

PVI and What Else for Persistent AF Lessons Learned from STAR AF 2 CCCEP 2015 October 31, New York

CARDIOINSIGHT TM NONINVASIVE 3D MAPPING SYSTEM CLINICAL EVIDENCE SUMMARY

How to improve procedural outcome of cryoballoon ablation in persistent AF Experience from Redo procedures

ABLATION TECHNIQUES FOR ATRIAL FIBRILLATION

Surgical Ablation: Which Lesion Set for Which Patient?

Catheter ABlation vs ANtiarrhythmic Drug Therapy in Atrial Fibrillation (CABANA) Trial

Percutaneous Transvenous Atrial Fibrillation Ablation and Stroke

AF Ablation in 2015 Why, Who, What and How? Steve Wilton ACC Rockies, Banff March 10, 2015

Indicatie voor ablatie bij voorkamerfibrillatie. Andrea Sarkozy Cardiologie Universitair Ziekenhuis Antwerpen

Combined catheter ablation and left atrial appendage closure as a. treatment of atrial fibrillation

Surgical Ablation of Atrial Fibrillation. Gregory D. Rushing, MD. Assistant Professor, Division of Cardiac Surgery

Thromboembolism During Sinus Rhythm in Patients with a History of Atrial Fibrillation

Κατάλυση παροξυσμικής κολπικής μαρμαρυγής Ποια τεχνολογία και σε ποιους ασθενείς; Χάρης Κοσσυβάκης Καρδιολογικό Τμήμα Γ.Ν.Α. «Γ.

AF Ablation in Patients with Heart Failure

AF :RHYTHM CONTROL BY DR-MOHAMMED SALAH ASSISSTANT LECTURER CARDIOLOGY DEPARTMENT

AF ABLATION Concepts and Techniques

Should AF patients (after ablation) have anticoagulation forever? Can we ever stop it?

Hybrid approaches in atrial fibrillation ablation: why, where and who?

Can the UK afford ablation for persistent AF? cost efficacy analysis. Dr Derick Todd Liverpool Heart & Chest Hospital

Post-ablation Management: Drug therapy, Anticoagulation and long-term Monitoring

What s New in the Guidelines for Surgical Ablation for Atrial Fibrillation?

Στροφείς (rotors) και πραγματικότητα. Χάρης Κοσσυβάκης Επιμελητής A Καρδιολογικό Τμήμα Γ.Ν.Α. «Γ. ΓΕΝΝΗΜΑΤΑΣ»

Contemporary Strategies for Catheter Ablation of Atrial Fibrillation

PRIMARY RESULTS OF RF CATHETER ABLATION FOR AF IN VIETNAM HEART INSTITUTE. PHAM QUOC KHANH, MD, PhD. et al Vietnam Heart Institute

Debate-STAR AF 2 study. PVI is not enough

Debate PRO. Dronedarone is an important drug in the management of paroxysmal atrial fibrillation. John Camm

Hybrid Ablation of AF in the Operating Room: Is There a Need? MAZE III Procedure. Spectrum of Atrial Fibrillation

Trial design and selection criteria

Ablation Should Not Be Used as Primary Therapy for Treatment of Patients with Atrial Fibrillation

Progression of atrial fibrillation: can we prevent it? Early catheter ablation will stop progression of atrial fibrillation pro

Catheter Ablation of Arrhythmias: Are the Results Different in the Elderly Patients?

When does enhanced monitoring for atrial fibrillation add value?

Raphael Rosso MD, Yuval Levi Med. Eng., Sami Viskin MD Tel Aviv Sourasky Medical Center

Clinical Practice Guidelines and the Under Treatment of Concomitant AF Vinay Badhwar, MD

Management of atrial fibrillation in heart failure

Atrial fibrillation from prevention to treatment

Does AF Ablation Lower Stroke Risk? Hugh Calkins MD Professor of Medicine Director of Electrophysiology Johns Hopkins Medical Institutions

Ruolo della ablazione della fibrillazione atriale nello scompenso cardiaco

Ablation Index : A new standard for Safety and Efficacy. Dr Franck Halimi Hôpital Privé Parly 2 Le Chesnay, France

Devices to Protect Against Stroke in Atrial Fibrillation

Device detected AF and atrial high rate episodes

Recurrent Stroke under Anticoagulation in Mild MS & AF

OAC after apparently successfull AF ablation: when, why, and how?

A Cryo Anatomical Procedure to Everyone? Saverio Iacopino, FACC, FESC

부정맥 3 Debaste 2. 08:30~10:00: 4 회의장

Mapping techniques in AFib. Helmut Pürerfellner, MD Public Hospital Elisabethinen Academic Teaching Hospital Linz, Austria

Should Paroxysmal Atrial Fibrillation be Treated During Cardiac Surgery?

Pulmonary vein isolation with complex fractionated atrial electrogram ablation for paroxysmal and nonparoxysmal atrial fibrillation: A meta-analysis

Spatio-temporal Dispersion: Mechanistic Significance

New technology to minimize radiation

Are Drugs Better? Dr Mauro Lencioni. Drugs or ablation as first line treatment for AF? Consultant Cardiologist & Electrophysiologist

Atrial Fibrillation and You

Modifiable Up-Stream Risk Factors:

Treating Atrial Fibrillation. Richard Schilling. St Bartholomew's Hospital, Queen Mary s University of London

New Guidelines: Surgical Ablation of Atrial Fibrillation. Niv Ad, MD

1995 Our First AF Ablation. Atrial Tachycardias During and After Atrial Fibrillation Ablation. Left Atrial Flutter. 13 Hours Later 9/25/2009

SUPPLEMENTARY INFORMATION

Minimally Invasive Stand Alone Cox-Maze Procedure For Patients With Non-Paroxysmal Atrial Fibrillation

EHRA/EUROPACE 2011 Madrid, Spain June

Storia dell ablazione della fibrillazione atriale: da dove siamo partiti, dove siamo, dove andremo. Prof. Fiorenzo Gaita

Atrial Fibrillation and Heart Failure: Rate vs. Rhythm Control Time for Re-evaluation

University of Groningen. Ablation of atrial fibrillation de Maat, Gijs Eduard

How to Distinguish Focal Atrial Tachycardia from Small Circuits and Reentry

Invasive and Medical Treatments for Atrial Fibrillation. Thomas J Dresing, MD Section of Electrophysiology and Pacing Cleveland Clinic

Dipen Shah Cardiology Service, University Hospitals, Geneva Switzerland

CATHETER ABLATION FOR ATRIAL FIBRILLATION WHEN and HOW

Atrial Fibrillation 2009

AF and arrhythmia management. Dr Rhys Beynon Consultant Cardiologist and Electrophysiologist University Hospital of North Staffordshire

심방세동과최신항응고요법 RACE II AFFIRM 항응고치료는왜중요한가? Rhythm control. Rate control. Anticoagulation 남기병 서울아산병원내과. Clinical Impact of Atrial Fibrillation

Transcription:

Catheter Ablation of Atrial Fibrillation Persistent Atrial Fibrillation Catheter Ablation : where are we? F. HIDDEN-LUCET francoise.hidden-lucet@aphp.fr Pitié-Salpétrière APHP FRANCE

Disclosure Statement of Financial Interest I currently have, or have had over the last two years, an affiliation or financial interests or interests of any order with a company or I receive compensation or fees or research grants with a commercial company : Compensation for courses: MEDA Research Grants: Biotronik, Boston Scientific France, Medtronic France Consultant: Biotronik, Medtronic France

Shall we perform it? Randomised trials RFCA or surgical ablation (lone AF) vs AA drugs, non parox AF, 12 Mo FU min. 3 studies (Forleo 2009, Stabile 2006, Mont 2014) : 261 pts (RFCA 159, AA 102) Primary End Point : Freedom of Atrial Arrhythmias, Need for Cardioversion, Cardiac Hospitalisation Secondary End Point : Significant bradycardia, periprocedural complication, all cause mortality, fatal or non fatal stroke, QOL. NYONG et al. Cochrane Database of Systematic Reviews 2016; Issue 11. Art CD012088

Shall we perform it? NYONG et al. Cochrane Database of Systematic Reviews 2016; Issue 11. Art CD012088

What technique shall we use? KIRCHHOF P. et al. ESC HERA EACTS ESO Guidelines 2016. Europace 2016;18:1609-1678 VERMA A. et al N Engl J Med 2015;372:1812-22

Why linear lesions and CFAEs have been of limited help? Linear lesions : pale copy of MAZE procedure Incomplete lines lead to high % of AT Anatomical and not tailored pt Various appreciation of CFAEs Various end point (domestication, total elimination) Not a reproducible technique ablation NADEMANEE et Al. J Am Coll Cardiol 2004; 43:2044 53 CONTI S. et al Heart Rhythm 2016;13:2101-2103

Towards a more tailored ablation technique : Rotors ablation? 43 pts, 21% parox AF, 72% prior PVI Rotors mapped in spontaneous (52%) or induced (49%) and alated (5% SR restauration) Low efficacy : mapping technique, comprehensive mechanism? STEINBERG JS. Et al. Heart Rhythm 2016;0:1-6 ZAMANJA. et al. 2015

Towards a more tailored ablation technique : Low Voltage Areas Meta analysis : PVI + LVA ablation compared to PVI alone or associated to conventional wide empirical ablation (CFAEs) 6 studies, 885 pts (64% Persistent AF + 28% long standing AF). FU 17 Mo. Results favouring PVI + LVA ablation: More Effective vs PVI + PVI and wide ablation (FA/TA free) 70% vs 43%, OR = 3.41, 95%CI 2.22-5.24, p<0.001 Less AT (vs PVI + extensive RF) : 14% vs 46%, OR=0.16, 95%CI 0.07-0.37, p<0.001 Lower procedure time : 176 min vs 220 min, OR = 0.36, 95%CI 0.24-0.56, p<0.001 Lower fluoroscopy time : 25 min vs 32 min, OR = 0.22, 95%CI 0.12-0.39, p<0.001 Lower RF time : 55 min vs 90 min,or = 0.49, 95%CI 0.27-0.90, p=0.021 BLANDINO A. et al. doi:1011/pace.13015

Towards a more tailored ablation technique : Low Voltage Areas 201 pts, 82% permanent AF. Mapping LVA (bipolar EGM < 0.5 mv in AF), then PVI, then LVA ablation if present. LVA performed in 159 pts. High comparable SR rate at FU (3.1 Years) Remaining questions : catheter used, value of 0.5 MV in AF (what about SR? ), no randomisation, correlation with anatomic fibrosis? YAGISHITA A.et al. J Cardiovasc Electrophysiol 2016 doi:10.111/jce.13122

Towards a more tailored ablation technique : Spatiotemporal Electrogram Dispersion Endocardial mapping in AF with a PentaRay catheter : cartography of spatio-temporal dispersion (vicinity of a driver). 105 pts. Ablation at dispersion sites : termination of AF in 95% FU 18 Mo. Comparison with 47 pts with a classic stepwise ablation. SEITZ J. et al J Am Coll Cardiol 2017;69:303-21

Towards a more tailored ablation technique : Spatiotemporal Electrogram Dispersion FU at M 18 Single Procedure Spatiotemporal Electrogram Dispersion (n=105) Multiple Procedures Classic Stepwise ablation (n=47) Recurrent rate 15%(1.4 + 0.4 procedure/pt) 41%% (1.5 + 0.5 procedure/pt) < 0.001 RF Time (min) 49 + 21 85 + 34.5 0.001 Procedure Time (min) 168 + 42 230 + 67 < 0.0001 p SEITZ J. et al J Am Coll Cardiol 2017;69:303-21

Targetting Difficult Patients : Surgical or Hybrid Therapy More extensive lesions on the epicardial site Thoracoscopy : non incision Concomittant appendage exclusion Courtesy C.D ALESSANDRO Pitié Salpétrière

Targetting Difficult Patients : Surgical or Hybrid Therapy 78 pts Median FU 24 Mo Endocardial touch up to complete the box : 38% PISON L. et al. Ann Cardiothorac Surg 2014;3(1):38-44

Recent Guidelines Recommandations «There is no current indication for catheter ablation to prevent cardiovascular outcomes (or desired withdrawal of anticoagulation), or to reduce hospitalization». «For patients with persistent AF, ablation of complex fractionated electrograms, ablation of rotors, or routine deployement of linear lesions or another additional ablations does not seem justified in the first procedure» «However, additional ablation on top of complete PVI may be considered in patients with recurrent AF after the initial AF ablation procedure». KIRCHHOF P. et al. ESC HERA EACTS ESO Guidelines 2016. Europace 2016;18:1609-1678

Where are We? Still in a moving field!!! PVI remains the corner stone for persistent AF ablation in the guidelines Tailored ablations techniques focusing on AF mechanism and imaging developpement improving but need randomised studies and reproducibility Surgery and hybrid therapy welcome in the guidelines due to mini invasive techniques. KIRCHHOF P. et al. ESC HERA EACTS ESO Guidelines 2016. Europace 2016;18:1609-1678